Try our Advanced Search for more refined results
Private Equity
Private Equity Law360 provides breaking news and analysis on private equity deals and the attorneys involved. Coverage includes high-impact deals, related litigation and enforcement actions, and policy developments that affect private equity firms.
Sign up for a 7-day FREE trial today!
Latest News in Private Equity
-
January 21, 2025
Bacon Giant Smithfields Leads 3 IPOs Primed To Exceed $1B
Bacon maker Smithfields Foods Inc. led a trio of companies unveiling price ranges for initial public offerings Tuesday that could raise $1.3 billion combined over the next week, with 10 law firms guiding the IPOs in various capacities.
-
January 21, 2025
The Blueprint For A National Bitcoin Reserve
The new administration has the opportunity to pave the way for a U.S.-backed crypto reserve, which could conceptually function as a strategic asset akin to traditional reserves like gold markets, hedge against economic instability, and influence global crypto adoption, say attorneys at Duane Morris.
-
January 21, 2025
Ex-Chemical Biz Atty Drops Claims Against Bain Capital
A former in-house attorney for chemicals company Arxada has agreed to remove Bain Capital as a defendant in her New Jersey state court suit alleging that she was unlawfully dismissed after she discussed taking leave to recover from a miscarriage.
-
January 21, 2025
New SEC Task Force Eyes 'Sensible' Crypto Regulations
A day after being appointed acting chairman of the U.S. Securities and Exchange Commission, Mark T. Uyeda on Tuesday launched a cryptocurrency task force to develop "a comprehensive and clear regulatory framework" for such assets.
-
January 21, 2025
Pactiv Evergreen's $6.7B Sale To Novolex Goes Unchallenged
Food merchandising product maker Pactiv Evergreen on Tuesday revealed that the waiting period for its $6.7 billion merger with packaging products manufacturer Novolex has expired, clearing the path for the deal to close.
Areas of Coverage
- TRANSACTIONS
- Private equity deals valued at $50MM or more
- Venture capital investments of $25MM or more
- Mergers and acquisitions
- Capital investments, including mezzanine and growth capital deals
- Joint ventures involving private equity firms
- Hostile takeovers and leveraged buyouts
- Distressed investment deals
- AGENCIES
- U.S. Commodity Futures Trading Commission
- Federal Trade Commission
- Financial Industry Regulatory Authority
- Public Company Accounting Oversight Board
- U.S. Department of Justice
- U.S. Department of the Treasury
- U.S. Securities and Exchange Commission
- International competition and securities regulators
- POLICY & REGULATION
- Dodd-Frank Act
- Delaware corporate law
- Antitrust and consumer protection controls
- Private equity industry lobbying
- International banking legislation and regulation
- ENFORCEMENT
- Merger reviews
- Second requests
- Challenges and divestitures
- Litigation
- Antitrust suits
- Shareholder disputes
- Corporate governance fights
- Poison pill challenges
- Hostile takeover disputes
- Privacy and consumer protection suits
- Bankruptcy proceedings involving private equity stakeholders
- PROFILES
- Personnel moves
- Profiles of private equity practices
Readership
- Private equity lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the private equity industry
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals